$35.3MVenture, 2 October 2025
New equity funds clinical development of the PanFlu nasal spray and its mucosal pipeline.
- Amount
- $35.3M
- Stage
- Venture
- Announced
- 2 October 2025
- Lead
- EIC Fund
- Other investors
- Invest-NL
- Use of funds
- New equity funds clinical development of the PanFlu nasal spray and its mucosal pipeline.
- Checked
- Announced by the company
- Sources
- Leyden Labs raises €30M Funding round (amount in EUR as listed by tech.eu) businesswire.com
Leyden Labs raises €30M Funding round (amount in EUR as listed by tech.eu) funding.tech.eu